Cencora Inc. ($COR) Stock Forecast: Up 5.1% Today

What is Cencora Inc.?

Cencora Inc. (NYSE: COR) is a healthcare solutions company that had a strong bullish movement in the stock market today.

Why is Cencora Inc. going up?

COR stock is up 5.1% on Nov 6, 2024 19:46

• In the fourth quarter of 2024, COR exceeded sales expectations, seeing a significant revenue increase in both U.S. and International Healthcare Solutions segments.
• Despite a year-over-year decline in margins, COR's overall Q4 performance was impressive, resulting in an increased dividend and positive market sentiment.
• Analysts were optimistic about COR's earnings and revenue estimates, suggesting potential for ongoing stock growth.
• The market responded positively to COR's better-than-expected Q4 earnings and revenue, propelling the bullish movement in the stock price.

COR Price Chart

COR Technical Analysis

COR News

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings - Cencora ( NYSE:COR )

On Wednesday, Cencora, Inc.'s COR fourth-quarter 2024 sales increased 14.7% to $79.1 billion, beating the consensus of $77.65 billion. The sales jump reflects a 15.7% increase in revenue within U.S. Healthcare Solutions and a 5.5% increase in revenue within International Healthcare Solutions.

https://www.benzinga.com/news/earnings/24/11/41780082/cencora-acquires-retina-care-practice-network-for-4-6-billion-boosts-dividend-on-better-than-expect

Cencora Q4 Earnings & Revenues Beat Estimates, Margins Decline Y/Y

COR's fourth-quarter fiscal 2024 results showcase a strong segmental performance.

https://www.zacks.com/stock/news/2365400/cencora-q4-earnings-revenues-beat-estimates-margins-decline-yy

Cencora ( COR ) Tops Q4 Earnings and Revenue Estimates

Cencora (COR) delivered earnings and revenue surprises of 4.05% and 1.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2364930/cencora-cor-tops-q4-earnings-and-revenue-estimates

Cencora to Report Q4 Earnings: What's in Store for the Stock?

COR's fiscal fourth-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.

https://www.zacks.com/stock/news/2363707/cencora-to-report-q4-earnings-whats-in-store-for-the-stock

Cencora ( COR ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.

https://www.zacks.com/stock/news/2362485/cencora-cor-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures

Trending Today

Solana ($SOL) Crypto Forecast: Up 5.0% Today

Avalanche ($AVAX) Crypto Forecast: Up 11.3% Today

Cardano ($ADA) Crypto Forecast: Up 17.1% Today

American Eagle Outfitters Inc. ($AEO) Stock Forecast: Up 5.1% Today

Zoom Video Communications Inc. ($ZM) Stock Forecast: Up 5.2% Today

Transdigm Group Incorporated Inc. ($TDG) Stock Forecast: Down 5.2% Today

AbbVie Inc. ($ABBV) Stock Forecast: Up 5.3% Today

Carvana Co ($CVNA) Stock Forecast: Up 5.2% Today

Virgin Galactic Holdings Inc ($SPCE) Stock Forecast: Up 5.1% Today

Foot Locker Inc. ($FL) Stock Forecast: Up 5.1% Today

Cencora Inc. Price History

06.10.2024 - COR Stock was up 5.1%

• In the fourth quarter of 2024, COR exceeded sales expectations, seeing a significant revenue increase in both U.S. and International Healthcare Solutions segments.
• Despite a year-over-year decline in margins, COR's overall Q4 performance was impressive, resulting in an increased dividend and positive market sentiment.
• Analysts were optimistic about COR's earnings and revenue estimates, suggesting potential for ongoing stock growth.
• The market responded positively to COR's better-than-expected Q4 earnings and revenue, propelling the bullish movement in the stock price.

15.09.2024 - COR Stock was up 2.3%

• COR experienced a strong bullish movement recently, possibly due to investor optimism and confidence in the company's financial performance.
• Expectations of COR surpassing earnings estimates in the near future may have influenced the positive market sentiment.
• The consistent outperformance of COR compared to the market could have attracted more investors, boosting the stock price.
• In summary, COR's solid historical performance, anticipated positive earnings, and market outperformance likely drove the recent bullish movement in the stock.

15.09.2024 - COR Stock was up 5.7%

• Cencora's stock price surged today as investors continue to be impressed by its consistent outperformance compared to the market over the past 5 years.
• The significant growth of $1000 invested in Cencora 5 years ago to $2,700 today likely attracted more investors to the stock, driving up demand.
• The market capitalization of $43.54 billion indicates strong investor confidence in Cencora's future growth prospects, further fueling today's bullish movement.
• Overall, Cencora's impressive track record and positive market sentiment seem to have contributed to today's strong bullish performance.

28.02.2024 - COR Stock was down 0.9%

• The bearish movement in COR stock today could be attributed to investors' concerns about the stiff competition in the U.S. Healthcare Solutions segment.
• Despite the company gaining traction in the industry, the competitive landscape might be causing uncertainty among investors, leading to a sell-off of the stock.
• Investors may be reevaluating the growth potential of COR amidst the challenges posed by its competitors, resulting in the bearish market movement today.

01.01.2024 - COR Stock was up 5.5%

• Cencora's short interest has risen, indicating potential buying pressure from investors.
• The company's first quarter adjusted EPS and revenue exceeded expectations, showing strong financial performance.
• The bullish options activity suggests a positive sentiment among investors.
• The overall market growth, including the rising demand for GLP-1 drugs and COVID-19 vaccines, contributed to Cencora's positive performance.

27.05.2024 - COR Stock was down 5.1%

• The recent decline in COR stock may be due to:
• Competition in the healthcare solutions sector impacting the company's growth outlook.
• Investor doubts about the company's competitive position despite its potential.
• Changes in market sentiment, potentially influenced by profit-taking or broader market conditions, contributing to the stock's downward trend.